Floatz logo

Therapeutic Asset Ratings

120 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cetuximab
Metastatic Colorectal Cancer
Shanghai Henlius BiotechP4BB (70)
FLUOROURACILUM
Metastatic Colorectal Cancer
Washington University School of MedicineP4BB (70)
PANITUMUMAB
Metastatic Colorectal Cancer
M.D. Anderson Cancer CenterP3BB (70)
Eloxatin
Metastatic Colorectal Cancer
Allama Iqbal Medical CollegeP3BB (69)
Regorafenib
Metastatic Colorectal Cancer
China Medical University, ChinaP4BB (68)
Irinotecan
Metastatic Colorectal Cancer
City of Hope Medical CenterP3BB (68)
Fruquintinib
Metastatic Colorectal Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P4BB (67)
TIPIRACIL
Metastatic Colorectal Cancer
M.D. Anderson Cancer CenterP3BB (67)
Trifluridine
Metastatic Colorectal Cancer
M.D. Anderson Cancer CenterP3BB (67)
Capecitabine
Metastatic Colorectal Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (66)
Levoleucovorin
Metastatic Colorectal Cancer
Azienda USL Reggio Emilia - IRCCSP3BB (65)
Ivonescimab
Metastatic Colorectal Cancer
UNICANCERP3BB (64)
Encorafenib
Metastatic Colorectal Cancer
M.D. Anderson Cancer CenterP2BB (64)
Silymarin
Metastatic Colorectal Cancer
Tanta UniversityP4B (63)
Abt-301
Metastatic Colorectal Cancer
Anbogen Therapeutics, Inc.P3B (63)
Cyclophosphamide
Metastatic Colorectal Cancer
City of Hope Medical CenterP2B (61)
Nivolumab
Metastatic Colorectal Cancer
Fred Hutchinson Cancer CenterP3B (60)
Pembrolizumab
Metastatic Colorectal Cancer
National Cancer Center Hospital EastP2B (60)
Catequentinib
Metastatic Colorectal Cancer
Fudan UniversityP2/3B (60)
Sotorasib
Metastatic Colorectal Cancer
M.D. Anderson Cancer CenterP3B (59)
Tas-102
Metastatic Colorectal Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.P3B (59)
Adagrasib
Metastatic Colorectal Cancer
M.D. Anderson Cancer CenterP3B (58)
Olaparib
Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer DigestivoP3B (58)
Palbociclib
Metastatic Colorectal Cancer
Oslo University HospitalP2B (58)
POLO-LIKE KINASE 1 INHIBITOR NMS-1286937
Metastatic Colorectal Cancer
Cardiff OncologyP2B (58)
Showing 1 to 25 of 120 assets
PreviousPage 1 of 5Next